Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Autism Speaks Launches Venture Philanthropy Arm

This article was originally published in The Pink Sheet Daily

Executive Summary

Autism Speaks, an advocacy group that has devoted nearly $200 million to basic research on autism spectrum disorders since 2005, is spinning out a venture arm called Delivering Scientific Innovation for Autism to fund efforts by the for-profit sector. The amount of funding involved is “not insignificant,” said Robert Ring, who left Pfizer in 2011 to spearhead the move into the transitional space.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS073418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel